Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype

被引:23
作者
Li, Dan [1 ,2 ]
Xie, Peng [2 ]
Mi, Can [1 ]
机构
[1] Chongqing Med Univ, Dept Pathol, Fac Basic Med, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China
关键词
Primary testicular lymphoma; Diffuse large B-cell lymphoma; Subclassification; Activated B-cell-like subtype; Immunohistochemistry; PRIMARY FOLLICULAR LYMPHOMA; NON-HODGKINS-LYMPHOMA; GERMINAL CENTER; PROGNOSTIC-FACTORS; TESTIS; PLASMACYTOMA; EPIDIDYMIS; PATTERNS; CHEMOTHERAPY; CHILDHOOD;
D O I
10.1016/j.prp.2010.04.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The most common type of primary testicular lymphoma is diffuse large B-cell type, which has a poor prognosis relative to other extra-nodal diffuse large B-cell lymphomas (DLBCL). These constitute a heterogeneous group of lymphomas with germinal center B-cell-like and activated B-cell-like subtypes. Such a distinction theoretically utilizes the immunohistochemical expression of CD10, Bcl-6, and MUM1. The purpose of this study was that we could stratify primary testicular lymphoma of diffuse large B-cell type according to this scheme, and further elucidate the reason why primary testicular diffuse large B-cell lymphoma possesses a poor clinical outcome. Seventeen Chinese patients with primary testicular DLBCL were examined by means of a 3-antibody panel (CD10, Bcl-6, MUM1). Among these 17 cases, 16 were assigned to the activated B-cell-like subtypes. One case was classified as germinal center B-cell-like type. Twelve of these 17 cases expressed high proliferative activity (>= 40% Ki-67 labeling). The majority of primary testicular DLBCLs have activated B-cell-like subtype characteristics and high proliferative activity. These features might be a significant factor; moreover, they are associated with poor prognosis. Crown Copyright (C) 2010 Published by Elsevier GmbH. All rights reserved.
引用
收藏
页码:611 / 615
页数:5
相关论文
共 37 条
  • [21] Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres
    Lagrange, JL
    Ramaioli, A
    Theodore, C
    Terrier-Lacombe, MJ
    Beckendorf, V
    Biron, P
    Chevreau, C
    Chinet-Charrot, P
    Dumont, J
    Delobel-Deroide, A
    D'Anjou, J
    Chassagne, C
    Parache, RM
    Karsenty, JM
    Mercier, J
    Droz, JP
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (09) : 1313 - 1319
  • [22] Lu D, 2001, ARCH PATHOL LAB MED, V125, P551
  • [23] MOUSA AAA, 2006, MODERN PATHOL, V19, P1521
  • [24] Histopathologic and molecular aspects of CD56+natural killer/T-cell lymphoma of the testis
    Ornstein, Deborah L.
    Bifulco, Carlo B.
    Braddock, Demetrios T.
    Howe, John G.
    [J]. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2008, 16 (03) : 291 - 300
  • [25] Follicular large cell lymphoma localized to the testis in children
    Pakzad, K
    MacLennan, GT
    Elder, JS
    Flom, LS
    Trujillo, YP
    Sutherland, SE
    Meyerson, HJ
    [J]. JOURNAL OF UROLOGY, 2002, 168 (01) : 225 - 228
  • [26] Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics
    Pileri, SA
    Sabattini, E
    Rosito, P
    Zinzani, PL
    Ascani, S
    Fraternali-Orcioni, G
    Gamberi, B
    Piccioli, M
    Vivenza, D
    Falini, B
    Gaidano, G
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (09) : 684 - 688
  • [27] Testicular plasmacytoma in a patient with the acquired immunodeficiency syndrome
    Ramadan, A
    Naab, T
    Frederick, W
    Green, W
    [J]. TUMORI, 2000, 86 (06) : 480 - 482
  • [28] The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
    Rosenwald, A
    Wright, G
    Chan, WC
    Connors, JM
    Campo, E
    Fisher, RI
    Gascoyne, RD
    Muller-Hermelink, HK
    Smeland, EB
    Staudt, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (25) : 1937 - 1947
  • [29] Primary large-cell non-Hodgkin's lymphoma of the testis: A retrospective analysis of patterns of failure and prognostic factors
    Seymour, JF
    Solomon, B
    Wolf, MM
    Janusczewicz, EH
    Wirth, A
    Prince, HM
    [J]. CLINICAL LYMPHOMA, 2001, 2 (02): : 109 - 115
  • [30] Stein H, 2008, WHO CLASSIFICATION T, P233